News

uMotif CEO Steve Rosenberg, Visionary Clinical Trial Technology Leader, to Retire; Industry Veteran and uMotif COO Andrea Valente to Take on Top Role 
News

uMotif CEO Steve Rosenberg, Visionary Clinical Trial Technology Leader, to Retire; Industry Veteran and uMotif COO Andrea Valente to Take on Top Role 

Read More
uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025
Press Release

uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025

Read More
The imperative for patient centricity in clinical research in the Age of AI 
Article

The imperative for patient centricity in clinical research in the Age of AI 

Read More
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up 
Article

The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up 

Read More
Trendspotting: Embracing AI, DEI Changes, Restrategizing Research Sites
Article

Trendspotting: Embracing AI, DEI Changes, Restrategizing Research Sites

Read More
Why the Patient–Site Relationship Is the Most Critical Factor in Clinical Trials​
Video

Why the Patient–Site Relationship Is the Most Critical Factor in Clinical Trials​

Read More
Patients and sites: fostering a partnership for the future of clinical trials
Article

Patients and sites: fostering a partnership for the future of clinical trials

Read More
uMotif: Patient-Centricity Took Flight Again in 2025
Article

uMotif: Patient-Centricity Took Flight Again in 2025

Read More
uMotif Chief Scientific Officer Leads Publication of Fundamental Work Detailing Industry-Wide Recommendations for Adopting Event-Driven eDiaries in Clinical Trials
Press Release

uMotif Chief Scientific Officer Leads Publication of Fundamental Work Detailing Industry-Wide Recommendations for Adopting Event-Driven eDiaries in Clinical Trials

Read More